- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1749-0774
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
mTOR inhibitor everolimus reduces invasiveness of melanoma cells ; volume:33 ; number:1 ; day:4 ; month:10 ; year:2019 ; pages:88-97 ; date:1.2020
Human cell ; 33, Heft 1 (4.10.2019), 88-97, 1.2020
- Creator
-
Ciołczyk-Wierzbicka, Dorota
Gil, Dorota
Zarzycka, Marta
Laidler, Piotr
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13577-019-00270-4
- URN
-
urn:nbn:de:101:1-2020042005372131582920
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ciołczyk-Wierzbicka, Dorota
- Gil, Dorota
- Zarzycka, Marta
- Laidler, Piotr
- SpringerLink (Online service)
Other Objects (12)
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
Systems analysis identifies miR-29b regulation of invasiveness in melanoma
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential
The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Bacterial invasiveness
MMP3 activity rather than cortical stiffness determines NHE1-dependent invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
Systems analysis identifies miR-29b regulation of invasiveness in melanoma
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential
The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Bacterial invasiveness
MMP3 activity rather than cortical stiffness determines NHE1-dependent invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
Systems analysis identifies miR-29b regulation of invasiveness in melanoma
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential
The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Bacterial invasiveness